Publications by authors named "Anselm Morell"

Claim this Profile
M
Mechanisms underlying corticosteroid resistance in patients with asthma: a review of current knowledge.
Javier Milara, Anselm Morell, Inés Roger, Paula Montero, Julio Cortijo

Expert Rev Respir Med· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Obacunone Photoprotective Effects against Solar-Simulated Radiation-Induced Molecular Modifications in Primary Keratinocytes and Full-Thickness Human Skin.
Paula Montero, Maria José Villarroel, Inés Roger, Anselm Morell, Javier Milara

Int J Mol Sci· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isocitrate dehydrogenase 2 inhibitor enasidenib synergizes daunorubicin cytotoxicity by targeting aldo-keto reductase 1C3 and ATP-binding cassette transporters.
Anselm Morell, Youssif Budagaga, Dimitrios Vagiannis, Yu Zhang, Lenka Laštovičková

Arch Toxicol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tepotinib Inhibits Several Drug Efflux Transporters and Biotransformation Enzymes: The Role in Drug-Drug Interactions and Targeting Cytostatic Resistance In Vitro and Ex Vivo.
Dimitrios Vagiannis, Youssif Budagaga, Anselm Morell, Yu Zhang, Eva Novotná

Int J Mol Sci· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of AKR1B10-mediated metabolism of daunorubicin as a novel off-target effect for the Bcr-Abl tyrosine kinase inhibitor dasatinib.
Neslihan Büküm, Eva Novotná, Anselm Morell, Jana Želazková, Lenka Laštovičková

Biochem Pharmacol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
β2-adrenoreceptors control human skin microvascular reactivity.
Anselm Morell, Javier Milara, Laurabel Gozalbes, Amedeu Gavaldà, Gema Tarrasón

Eur J Dermatol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective inhibition of aldo-keto reductase 1C3: a novel mechanism involved in midostaurin and daunorubicin synergism.
Anselm Morell, Eva Novotná, Jaroslav Milan, Petra Danielisová, Neslihan Büküm

Arch Toxicol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bruton's Tyrosine Kinase Inhibitors Ibrutinib and Acalabrutinib Counteract Anthracycline Resistance in Cancer Cells Expressing AKR1C3.
Anselm Morell, Lucie Čermáková, Eva Novotná, Lenka Laštovičková, Melodie Haddad

Cancers (Basel)· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interactions of antileukemic drugs with daunorubicin reductases: could reductases affect the clinical efficacy of daunorubicin chemoregimens?
Eva Novotná, Anselm Morell, Neslihan Büküm, Jakub Hofman, Petra Danielisová

Arch Toxicol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Entrectinib reverses cytostatic resistance through the inhibition of ABCB1 efflux transporter, but not the CYP3A4 drug-metabolizing enzyme.
Dimitrios Vagiannis, Zhang Yu, Eva Novotna, Anselm Morell, Jakub Hofman

Biochem Pharmacol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Pharmacokinetic Drug Resistance in Acute Myeloid Leukemia Cells with CDK4/6 Inhibitors.
Ales Sorf, Simona Sucha, Anselm Morell, Eva Novotna, Frantisek Staud

Cancers (Basel)· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclin-dependent kinase inhibitors AZD5438 and R547 show potential for enhancing efficacy of daunorubicin-based anticancer therapy: Interaction with carbonyl-reducing enzymes and ABC transporters.
Ales Sorf, Eva Novotna, Jakub Hofman, Anselm Morell, Frantisek Staud

Biochem Pharmacol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Buparlisib is a novel inhibitor of daunorubicin reduction mediated by aldo-keto reductase 1C3.
Neslihan Bukum, Eva Novotna, Anselm Morell, Jakub Hofman, Vladimir Wsol

Chem Biol Interact· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mucin 1 deficiency mediates corticosteroid insensitivity in asthma.
Javier Milara, Anselm Morell, Alfredo de Diego, Enrique Artigues, Esteban Morcillo

Allergy· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
JAK2 mediates lung fibrosis, pulmonary vascular remodelling and hypertension in idiopathic pulmonary fibrosis: an experimental study.
Javier Milara, Beatriz Ballester, Anselm Morell, José L Ortiz, Juan Escrivá

Thorax· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The JAK2 pathway is activated in idiopathic pulmonary fibrosis.
Javier Milara, Gracia Hernandez, Beatriz Ballester, Anselm Morell, Inés Roger

Respir Res· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MUC4 impairs the anti-inflammatory effects of corticosteroids in patients with chronic rhinosinusitis with nasal polyps.
Javier Milara, Anselm Morell, Beatriz Ballester, Miguel Armengot, Esteban Morcillo

J Allergy Clin Immunol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mucin 1 downregulation associates with corticosteroid resistance in chronic rhinosinusitis with nasal polyps.
Javier Milara, Teresa Peiró, Miquel Armengot, Soledad Frias, Anselm Morell

J Allergy Clin Immunol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Roflumilast improves corticosteroid resistance COPD bronchial epithelial cells stimulated with toll like receptor 3 agonist.
Javier Milara, Anselm Morell, Bea Ballester, Celia Sanz, Jose Freire

Respir Res· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis